, Singapore
391 views
Photo by Olga Kononenko for Unsplash

Enterprise SG's SEEDS Capital joins co-investment partnership

Startups will receive funding to access Cedars-Sinai's clinical resources.

Enterprise Singapore's investment arm SEEDS Capital, through Coronet Ventures, has partnered with Cedars Sinai Intellectual Property Company (CSIP) for a co-investment partnership.

Under the Startup SG Equity scheme, the co-investment partnership will invest in the country's healthcare and biomedical startups.

CSIP is the Cedars-Sinai Medical Centre's innovation arm.

The funding they receive would allow them to tap into the medical centre's clinical resources, such as exposure to research infrastructure and resources for clinical test-bedding.

READ MORE: Services from healthcare providers in Singapore slightly grew in Q1 23

The partnership will also allow the startups to benefit from mentorship opportunities from world-leading physicians, researchers, and other global healthcare entrepreneurs.

Over the next five years, Coronet Ventures aims to invest US$50m ($67.6m) in 12 to 15 Singapore startups.

Jeffrey Siow, Chairman of SEEDS Capital and Managing Director of Enterprise Singapore, said the co-investment partnership "will extend Singapore's presence in the US healthcare and startup ecosystems and give our startups a head-start to build track records and hopefully create global social impact."

Disclaimer: The article has been amended to remove inaccurate information. The factual information is highlighted in bold.

Join Singapore Business Review community

Follow the link for more news on

Join Singapore Business Review community
A NOTE FROM SINGAPORE BUSINESS REVIEW

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.

Top News

Access Partnership closes $16.6m raise with Mayfair and Kartesia
The firm plans to use the capital for acquisitions and to deepen its global footprint.
Saudi Arabia may set up crude oil storage in Singapore
The joint venture will commence in Jurong Island in the second half of 2027.